Adicet Bio, Inc. Weighted Average Limited Partnership Units Outstanding, Diluted
Adicet Bio, Inc. (ACET) reported Weighted Average Limited Partnership Units Outstanding, Diluted of 10.75 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageLimitedPartnershipUnitsOutstandingDiluted · last filed 2026-08-05
- Adicet Bio, Inc. weighted average limited partnership units outstanding, diluted for the quarter ending 2026-06-30 was 10.75M shares, a 88.76% increase year-over-year.
- Adicet Bio, Inc. weighted average limited partnership units outstanding, diluted for the quarter ending 2026-03-31 was 10.74M shares, a 88.77% increase year-over-year.
- Adicet Bio, Inc. weighted average limited partnership units outstanding, diluted for the quarter ending 2025-09-30 was 91.09M shares, a 0.26% increase year-over-year.
- Adicet Bio, Inc. weighted average limited partnership units outstanding, diluted for the quarter ending 2025-06-30 was 5.69M shares, a 93.72% decline year-over-year.
- Adicet Bio, Inc. weighted average limited partnership units outstanding, diluted for fiscal 2025 was 6.89M shares, a 25.49% increase from fiscal 2024.
- Adicet Bio, Inc. weighted average limited partnership units outstanding, diluted for fiscal 2024 was 5.49M shares, a 87.24% decline from fiscal 2023.
- Adicet Bio, Inc. weighted average limited partnership units outstanding, diluted for fiscal 2023 was 43.04M shares, a 4.78% increase from fiscal 2022.
- Adicet Bio, Inc. weighted average limited partnership units outstanding, diluted for fiscal 2022 was 41.08M shares, a 32.72% increase from fiscal 2021.
| Period end | Weighted Average Limited Partnership Units Outstanding, Diluted 3 month | Weighted Average Limited Partnership Units Outstanding, Diluted 3 month as first filed | Weighted Average Limited Partnership Units Outstanding, Diluted 6 month | Weighted Average Limited Partnership Units Outstanding, Diluted 6 month as first filed | Weighted Average Limited Partnership Units Outstanding, Diluted 9 month | Weighted Average Limited Partnership Units Outstanding, Diluted 12 month | Weighted Average Limited Partnership Units Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 10.75M shares 10-Q · filed 2026-08-05 | 10.75M shares 10-Q · filed 2026-08-05 | |||||
| 2026-03-31 | 10.74M shares 10-Q · filed 2026-05-13 | ||||||
| 2025-12-31 | 6.89M shares 10-K · filed 2026-03-12 | ||||||
| 2025-09-30 | 91.09M shares 10-Q · filed 2025-11-05 | 91.32M shares 10-Q · filed 2025-11-05 | |||||
| 2025-06-30 | 5.69M shares 10-Q · filed 2026-08-05 | 91.09M shares 10-Q · filed 2025-08-07 | 5.71M shares 10-Q · filed 2026-08-05 | 91.12M shares 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 5.69M shares 10-Q · filed 2026-05-13 | 91.07M shares 10-Q · filed 2025-05-06 | |||||
| 2024-12-31 | 5.49M shares 10-K · filed 2026-03-12 | 87.87M shares 10-K · filed 2025-03-06 | |||||
| 2024-09-30 | 90.85M shares 10-Q · filed 2025-11-05 | 86.87M shares 10-Q · filed 2025-11-05 | |||||
| 2024-06-30 | 90.63M shares 10-Q · filed 2025-08-07 | 84.85M shares 10-Q · filed 2025-08-07 | |||||
| 2024-03-31 | 79.07M shares 10-Q · filed 2025-05-06 | ||||||
| 2023-12-31 | 43.04M shares 10-K · filed 2025-03-06 | ||||||
| 2023-09-30 | 42.98M shares 10-Q · filed 2024-11-06 | 43.00M shares 10-Q · filed 2024-11-06 | |||||
| 2023-06-30 | 42.96M shares 10-Q · filed 2024-08-13 | 42.96M shares 10-Q · filed 2024-08-13 | |||||
| 2023-03-31 | 42.96M shares 10-Q · filed 2024-05-14 | ||||||
| 2022-12-31 | 41.08M shares 10-K · filed 2024-03-19 | ||||||
| 2022-09-30 | 41.64M shares 10-Q · filed 2023-11-08 | 40.55M shares 10-Q · filed 2023-11-08 | |||||
| 2022-06-30 | 40.08M shares 10-Q · filed 2023-08-09 | 39.98M shares 10-Q · filed 2023-08-09 | |||||
| 2022-03-31 | 45.96M shares 10-Q · filed 2023-05-09 | ||||||
| 2021-12-31 | 30.95M shares 10-K · filed 2023-03-15 | ||||||
| 2021-09-30 | 31.88M shares 10-Q · filed 2022-11-08 | 29.95M shares 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | 31.82M shares 10-Q · filed 2022-08-10 | 28.98M shares 10-Q · filed 2022-08-10 | |||||
| 2021-03-31 | 26.10M shares 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |